Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Quehenberger

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Biochemia Medica|July 8, 2022
Assay validity of point-of-care platelet function tests in thrombocytopenic blood samplesConrad Lacom, Alexander Tolios, Markus W Löffler, et al.
Annals of Hematology|April 1, 2017
Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complicationsJulia Kraft, Raute Sunder-Plassmann, Christine Mannhalter, et al.
Wiener Klinische Wochenschrift|December 31, 2002
Endothelial cell activation and blood coagulation in critically ill patients with lung injuryCatharina Wenzel, Julia Kofler, Gottfried J Locker, et al.
Thrombosis and Haemostasis|May 12, 2010
The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trialLudwig Traby, Alexandra Kaider, Rainer Schmid, et al.
British Journal of Anaesthesia|November 4, 2023
Concentration-effect relationship for tranexamic acid inhibition of tissue plasminogen activator-induced fibrinolysis in vitro using the viscoelastic ClotPro® TPA-testChristoph Dibiasi, Stefan Ulbing, Dagmar Bancher-Todesca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 2005
The course of anticardiolipin antibody levels under immunoadsorption therapyAnna-Christine Hauser, Lorenz Hauser, Ingrid Pabinger-Fasching, et al.
Blood|July 20, 2002
Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolismIngrid Pabinger, Helga Grafenhofer, Paul A Kyrle, et al.
Haematologica|August 2, 2007
Risk of recurrence after a first venous thromboembolic event in young womenClarissa Laczkovics, Helga Grafenhofer, Alexandra Kaider, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 31, 2017
Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM)Petra Jilma-Stohlawetz, Susanne Fritsche-Polanz, Peter Quehenberger, et al.
International Journal of Molecular Sciences|December 23, 2022
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with CancerCornelia Englisch, Oliver Königsbrügge, Stephan Nopp, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Biochemia Medica|July 8, 2022
Assay validity of point-of-care platelet function tests in thrombocytopenic blood samplesConrad Lacom, Alexander Tolios, Markus W Löffler, et al.
Annals of Hematology|April 1, 2017
Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complicationsJulia Kraft, Raute Sunder-Plassmann, Christine Mannhalter, et al.
Wiener Klinische Wochenschrift|December 31, 2002
Endothelial cell activation and blood coagulation in critically ill patients with lung injuryCatharina Wenzel, Julia Kofler, Gottfried J Locker, et al.
Thrombosis and Haemostasis|May 12, 2010
The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trialLudwig Traby, Alexandra Kaider, Rainer Schmid, et al.
British Journal of Anaesthesia|November 4, 2023
Concentration-effect relationship for tranexamic acid inhibition of tissue plasminogen activator-induced fibrinolysis in vitro using the viscoelastic ClotPro® TPA-testChristoph Dibiasi, Stefan Ulbing, Dagmar Bancher-Todesca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 2005
The course of anticardiolipin antibody levels under immunoadsorption therapyAnna-Christine Hauser, Lorenz Hauser, Ingrid Pabinger-Fasching, et al.
Blood|July 20, 2002
Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolismIngrid Pabinger, Helga Grafenhofer, Paul A Kyrle, et al.
Haematologica|August 2, 2007
Risk of recurrence after a first venous thromboembolic event in young womenClarissa Laczkovics, Helga Grafenhofer, Alexandra Kaider, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 31, 2017
Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM)Petra Jilma-Stohlawetz, Susanne Fritsche-Polanz, Peter Quehenberger, et al.
International Journal of Molecular Sciences|December 23, 2022
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with CancerCornelia Englisch, Oliver Königsbrügge, Stephan Nopp, et al.
Pageof 14